Severe Hemophilia A Recruiting Phase 1 Trials for Ascorbic acid (DB00126)

Also known as: Severe Haemophilia A / Hemophilia A, Severe

IndicationStatusPhase
DBCOND0034640 (Severe Hemophilia A)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04864743A Study to Evaluate the Pharmacokinetics´╝îSafety and Tolerability of PEG Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for InjectionTreatment